 |
|
Hormone Replacement Therapy and Breast Cancer
Janet L. Stanford, PhD;
Noel S. Weiss, MD, DrPH
Arch Fam Med. 1996;5(6):349-350.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995;45:8-30.
FREE FULL TEXT
2. Ries LAG, Hankey BA, Kosary CL, Harras A, Edwards BK. SEER Cancer Statistics Review, 1973-1991. Bethesda, Md: National Cancer Institute; 1994. National Institutes of Health publication 94-2789. 3. Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev. 1993;15:66-79.
FREE FULL TEXT
4. Steinberg KK, Thacker SB, Smith J, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 1991;265:1985-1990.
FREE FULL TEXT
5. Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR, Hoover RN. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control. 1994;5:491-500.
PUBMED
6. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995;274:137-142.
FREE FULL TEXT
7. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol. 1995;142:788-795.
FREE FULL TEXT
8. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-1593.
FREE FULL TEXT
9. Bergkvist L. Adami H-O, Persson I, Hoover RN, Schairer CI. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989;321:293-297.
ABSTRACT
10. Gambrell RD Jr. Proposal to decrease the risk and improve the prognosis of breast cancer. Am J Obstet Gynecol. 1984;150:119-128.
PUBMED
11. Bergkvist L, Adami H-O, Persson I, Bergstrom R, Jrusemo UB. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogenprogestogen replacement therapy. Am J Epidemiol. 1989;130:221-228.
FREE FULL TEXT
12. Hunt K, Vessey M, McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol. 1990;97:1080-1086.
PUBMED
13. Harris RB, Laws A, Reedy VM, King A, Haskell WL. Are women using postmenopausal estrogens? A community survey. Am J Public Health. 1990;80:1266-1268.
FREE FULL TEXT
14. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 1991;115:455-456.
PUBMED
15. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol. 1993;46:211-219.
PUBMED
16. Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 1985;7:80-104.
FREE FULL TEXT
17. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178-208.
FREE FULL TEXT
18. Henderson BE, Ross RK, Lobo RA, Pike MC, Mack TM. Re-evaluating the role of progestogen therapy after the menopause. Fertil Steril. 1988;49(suppl):9S-15S.
PUBMED
19. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1038-1041.
FREE FULL TEXT
20. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of largebowel cancer. J Natl Cancer Inst. 1995;87:1067-1071.
FREE FULL TEXT
21. Potter JD. Hormones and colon cancer. J Natl Cancer Inst. 1995;87:1039-1040.
FREE FULL TEXT
|
